Massive left ventricular Pseudoaneurysm four weeks post-myocardial infarction and percutaneous coronary intervention:

Muhammad Umar Farooq1, Shabana Kausar1, Muhammad Fawad Tahir1,2

  • 1Department of Cardiology, Rawalpindi Institute of Cardiology, Rawal Road, Chaklala Cantt, 46000, Rawalpindi, Pakistan.

PubMed

Insights

Left ventricular pseudoaneurysms (LVPA) are rare post-myocardial infarction (MI) complications. This case highlights a massive LVPA, emphasizing multimodal imaging like cardiac MRI for diagnosis and management.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Left ventricular pseudoaneurysms (LVPA) are uncommon sequelae of myocardial infarction (MI).
  • Diagnosis can be difficult due to nonspecific symptoms, especially with large aneurysms.

Observation:

  • A 75-year-old male presented with chest pain following an inferior wall MI treated with PCI.
  • Echocardiography revealed an aneurysmal outpouching, later confirmed by CTA and CMR.

Findings:

  • The confirmed LVPA was unusually large, featuring a 30-mm neck, thrombus, and extensive myocardial damage.
  • Cardiac MRI (CMR) played a crucial role in delineating the aneurysm's size and characteristics.

Implications:

  • This case underscores the importance of advanced imaging, particularly CMR, in diagnosing massive LVPA.
  • Further research is needed to establish optimal treatment guidelines for these rare and complex cases.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
29
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
54